Skip to content
WealthTicker

Compare

NAVs as of 20 Aug 2026

Baroda BNP Paribas Balanced Advantage FundDirect1 of 4 funds

Add a second fund to compare. Until then every figure below is shown against the Dynamic Asset Allocation or Balanced Advantage median (37 funds), which is the only comparison one fund can support.

Growth of ₹100 (rebased over the selected window)

Common period 20 Nov 201820 Aug 2026, limited by Baroda BNP Paribas Balanced Advantage Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.

View as table
Growth of ₹100, sampled across the common period
DateBaroda BNP Paribas Balanced Advantage FundNifty 50
20 Nov 2018₹100.00₹100.00
14 Jul 2019₹106.68₹108.41
06 Mar 2020₹111.86₹103.13
28 Oct 2020₹130.91₹110.07
20 Jun 2021₹153.94₹147.18
11 Feb 2022₹168.10₹163.05
05 Oct 2022₹172.72₹162.11
29 May 2023₹185.65₹174.53
20 Jan 2024₹219.49₹202.91
12 Sep 2024₹257.19₹238.25
05 May 2025₹253.36₹229.55
27 Dec 2025₹276.08₹244.39
20 Aug 2026₹288.71₹227.40
Baroda BNP Paribas Balanced Advantage Fund compared on return, risk, benchmark-relative, cost and portfolio metrics, against the Dynamic Asset Allocation or Balanced Advantage median.
Metric
Baroda BNP Paribas · Direct
NAV ₹28.96
High risk
★★★★☆
Category median
Dynamic Asset Allocation or Balanced Advantage · 37 funds
+8.61%+4.48%
+13.90%+11.02%
+12.50%+10.08%
+10.76%
+14.66%+9.91%
+12.67%
+15.86%+12.11%
+16.04%+11.73%
+11.91%
Risk
10.44%8.34%
0.710.52
0.960.72
-20.72%-15.25%
Nifty 50
+5.27%+2.88%
0.780.62
92.7%73.8%
53.1%43.9%
0.95%1.04%
₹4,798Cr₹2,076Cr
Up to 1.00%
None
₹250
₹5.00K
378%185%
Sanjay Chawla · 7.8y
20 Nov 2018
61
24.3%
-1.5%

Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.